Concepedia

Aaron Miller

AM

Statistics

Publications

61

Citations

5.6K

H-Index

32

Active since

1957

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Ottawa

Ottawa Hospital

Sanofi (France)

The University of Texas Health Science Center at Houston

Aaron Miller is an author at Icahn School of Medicine at Mount Sinai specializing in multiple sclerosis, neurology, and multiple sclerosis therapy.

Publications per year

1957–2024

61

Publications

61

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 570 citations

Pharmacy, Neurology, Pharmacotherapy +10

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. · Journal of the National Comprehensive Cancer Network · 2023 · 520 citations · Full text

Medicine, Oncology, Pathology +17

A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

Murray B. Bornstein, Aaron Miller, Susan Slagle et al. · New England Journal of Medicine · 1987 · 463 citations

Life Sciences, Immunology, Neurology +15

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial

Jerry S. Wolinsky, Ponnada A. Narayana, Paul O’Connor et al. · Annals of Neurology · 2007 · 424 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 351 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

1–5 of 61